| **SEGMENT REPORTING (Selected Financial Information Relating To Company's Segments ) (Details) $ in Millions**       | 3 Months Ended | 12 Months Ended |
|----------------------------------------------------------------------------------------------------------------------|----------------|-----------------|
||
| **Segment Reporting [Abstract]**                                                                                     |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Number of reportable segments | reportable_segment                                                                   |           |            |   |   |   |   |   |   | 4 |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Net sales                                                                                                            | $ 1,627        | $ 1,551         | $ 1,473 | $ 1,563 |   |   |   |   | $ 6,214 |   |   |   |   |
| Net sales                                                                                                            |           |            |   |   | $ 1,691 | $ 1,517 | $ 1,416 | $ 1,500 |   | $ 6,124 | $ 5,973 | $ 5,761 | $ 5,655 |
| Earnings (losses) from continuing operations before income taxes                                                     |           |            |   |   |   |   |   |   | 1,024 | 1,054 | 1,033 |   |   |
| Income from equity investees                                                                                         |           |            |   |   |   |   |   |   | 15 | 12 | 19 |   |   |
| Total assets                                                                                                         | 5,116          |            |   |   | 5,060 |   |   |   | 5,116 | 5,060 | 4,573 | $ 4,510 | $ 4,154 |
| Capital expenditures                                                                                                 |           |            |   |   |   |   |   |   | 206 | 194 | 231 |   |   |
| Depreciation and amortization                                                                                        |           |            |   |   |   |   |   |   | 180 | 166 | 163 |   |   |
| Stock-based compensation                                                                                             |           |            |   |   |   |   |   |   | $ 43 | $ 53 | $ 51 |   |   |
| Net Sales [Member] | Product Concentration Risk [Member]                                                             |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 100.00% |   |   |   |   |
| Net Sales [Member] | Product Concentration Risk [Member]                                                             |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 100.00% | 100.00% |   |   |
| Cleaning [Member] | Net Sales [Member] | Product Concentration Risk [Member]                                         |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 34.00% |   |   |   |   |
| Cleaning [Member] | Net Sales [Member] | Product Concentration Risk [Member]                                         |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 34.00% | 34.00% |   |   |
| Cleaning [Member] | Home Care [Member] | Net Sales [Member] | Product Concentration Risk [Member]                    |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 19.00% |   |   |   |   |
| Cleaning [Member] | Home Care [Member] | Net Sales [Member] | Product Concentration Risk [Member]                    |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 19.00% | 19.00% |   |   |
| Cleaning [Member] | Laundry [Member] | Net Sales [Member] | Product Concentration Risk [Member]                      |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 9.00% |   |   |   |   |
| Cleaning [Member] | Laundry [Member] | Net Sales [Member] | Product Concentration Risk [Member]                      |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 9.00% | 9.00% |   |   |
| Cleaning [Member] | Professional Products [Member] | Net Sales [Member] | Product Concentration Risk [Member]        |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 6.00% |   |   |   |   |
| Cleaning [Member] | Professional Products [Member] | Net Sales [Member] | Product Concentration Risk [Member]        |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 6.00% | 6.00% |   |   |
| Household [Member] | Net Sales [Member] | Product Concentration Risk [Member]                                        |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 30.00% |   |   |   |   |
| Household [Member] | Net Sales [Member] | Product Concentration Risk [Member]                                        |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 32.00% | 33.00% |   |   |
| Household [Member] | Bags, Wraps, And Containers [Member] | Net Sales [Member] | Product Concentration Risk [Member] |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 13.00% |   |   |   |   |
| Household [Member] | Bags, Wraps, And Containers [Member] | Net Sales [Member] | Product Concentration Risk [Member] |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 14.00% | 14.00% |   |   |
| Household [Member] | Charcoal [Member] | Net Sales [Member] | Product Concentration Risk [Member]                    |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 8.00% |   |   |   |   |
| Household [Member] | Charcoal [Member] | Net Sales [Member] | Product Concentration Risk [Member]                    |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 9.00% | 10.00% |   |   |
| Household [Member] | Cat Litter [Member] | Net Sales [Member] | Product Concentration Risk [Member]                  |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 7.00% |   |   |   |   |
| Household [Member] | Cat Litter [Member] | Net Sales [Member] | Product Concentration Risk [Member]                  |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 7.00% | 7.00% |   |   |
| Household [Member] | Digestive Health [Member] | Net Sales [Member] | Product Concentration Risk [Member]            |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 2.00% |   |   |   |   |
| Household [Member] | Digestive Health [Member] | Net Sales [Member] | Product Concentration Risk [Member]            |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 2.00% | 2.00% |   |   |
| Lifestyle [Member] | Net Sales [Member] | Product Concentration Risk [Member]                                        |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 20.00% |   |   |   |   |
| Lifestyle [Member] | Net Sales [Member] | Product Concentration Risk [Member]                                        |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 17.00% | 16.00% |   |   |
| Lifestyle [Member] | Food Products [Member] | Net Sales [Member] | Product Concentration Risk [Member]               |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 9.00% |   |   |   |   |
| Lifestyle [Member] | Food Products [Member] | Net Sales [Member] | Product Concentration Risk [Member]               |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 9.00% | 9.00% |   |   |
| Lifestyle [Member] | Natural Personal Care [Member] | Net Sales [Member] | Product Concentration Risk [Member]       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 5.00% |   |   |   |   |
| Lifestyle [Member] | Natural Personal Care [Member] | Net Sales [Member] | Product Concentration Risk [Member]       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 4.00% | 4.00% |   |   |
| Lifestyle [Member] | Water Filtration [Member] | Net Sales [Member] | Product Concentration Risk [Member]            |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 3.00% |   |   |   |   |
| Lifestyle [Member] | Water Filtration [Member] | Net Sales [Member] | Product Concentration Risk [Member]            |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 3.00% | 3.00% |   |   |
| Lifestyle [Member] | Dietary Supplements [Member] | Net Sales [Member] | Product Concentration Risk [Member]         |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 3.00% |   |   |   |   |
| Lifestyle [Member] | Dietary Supplements [Member] | Net Sales [Member] | Product Concentration Risk [Member]         |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 1.00% | 0.00% |   |   |
| International [Member] | Net Sales [Member] | Product Concentration Risk [Member]                                    |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   | 16.00% |   |   |   |   |
| International [Member] | Net Sales [Member] | Product Concentration Risk [Member]                                    |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Concentration percentage                                                                                             |           |            |   |   |   |   |   |   |   | 17.00% | 17.00% |   |   |
| Operating Segments [Member] | Cleaning [Member]                                                                      |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Net sales                                                                                                            |           |            |   |   |   |   |   |   | $ 2,109 |   |   |   |   |
| Net sales                                                                                                            |           |            |   |   |   |   |   |   |   | $ 2,060 | $ 2,002 |   |   |
| Earnings (losses) from continuing operations before income taxes                                                     |           |            |   |   |   |   |   |   | 600 | 574 | 523 |   |   |
| Income from equity investees                                                                                         |           |            |   |   |   |   |   |   | 0 | 0 | 0 |   |   |
| Total assets                                                                                                         | 903            |            |   |   | 902 |   |   |   | 903 | 902 |   |   |   |
| Capital expenditures                                                                                                 |           |            |   |   |   |   |   |   | 49 | 60 | 76 |   |   |
| Depreciation and amortization                                                                                        |           |            |   |   |   |   |   |   | 52 | 49 | 51 |   |   |
| Stock-based compensation                                                                                             |           |            |   |   |   |   |   |   | 14 | 13 | 16 |   |   |
| Operating Segments [Member] | Household [Member]                                                                     |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Net sales                                                                                                            |           |            |   |   |   |   |   |   | 1,870 |   |   |   |   |
| Net sales                                                                                                            |           |            |   |   |   |   |   |   |   | 1,959 | 1,961 |   |   |
| Earnings (losses) from continuing operations before income taxes                                                     |           |            |   |   |   |   |   |   | 316 | 370 | 419 |   |   |
| Income from equity investees                                                                                         |           |            |   |   |   |   |   |   | 0 | 0 | 0 |   |   |
| Total assets                                                                                                         | 1,223          |            |   |   | 1,223 |   |   |   | 1,223 | 1,223 |   |   |   |
| Capital expenditures                                                                                                 |           |            |   |   |   |   |   |   | 81 | 73 | 82 |   |   |
| Depreciation and amortization                                                                                        |           |            |   |   |   |   |   |   | 67 | 65 | 64 |   |   |
| Stock-based compensation                                                                                             |           |            |   |   |   |   |   |   | 12 | 12 | 15 |   |   |
| Operating Segments [Member] | Lifestyle [Member]                                                                     |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Net sales                                                                                                            |           |            |   |   |   |   |   |   | 1,265 |   |   |   |   |
| Net sales                                                                                                            |           |            |   |   |   |   |   |   |   | 1,077 | 1,000 |   |   |
| Earnings (losses) from continuing operations before income taxes                                                     |           |            |   |   |   |   |   |   | 255 | 243 | 244 |   |   |
| Income from equity investees                                                                                         |           |            |   |   |   |   |   |   | 0 | 0 | 0 |   |   |
| Total assets                                                                                                         | 1,581          |            |   |   | 1,533 |   |   |   | 1,581 | 1,533 |   |   |   |
| Capital expenditures                                                                                                 |           |            |   |   |   |   |   |   | 39 | 22 | 30 |   |   |
| Depreciation and amortization                                                                                        |           |            |   |   |   |   |   |   | 31 | 23 | 20 |   |   |
| Stock-based compensation                                                                                             |           |            |   |   |   |   |   |   | 7 | 7 | 9 |   |   |
| Operating Segments [Member] | International [Member]                                                                 |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Net sales                                                                                                            |           |            |   |   |   |   |   |   | 970 |   |   |   |   |
| Net sales                                                                                                            |           |            |   |   |   |   |   |   |   | 1,028 | 1,010 |   |   |
| Earnings (losses) from continuing operations before income taxes                                                     |           |            |   |   |   |   |   |   | 96 | 84 | 81 |   |   |
| Income from equity investees                                                                                         |           |            |   |   |   |   |   |   | 15 | 12 | 19 |   |   |
| Total assets                                                                                                         | 1,027          |            |   |   | 1,045 |   |   |   | 1,027 | 1,045 |   |   |   |
| Capital expenditures                                                                                                 |           |            |   |   |   |   |   |   | 26 | 33 | 37 |   |   |
| Depreciation and amortization                                                                                        |           |            |   |   |   |   |   |   | 25 | 24 | 22 |   |   |
| Stock-based compensation                                                                                             |           |            |   |   |   |   |   |   | 1 | 1 | 2 |   |   |
| Corporate, Non-Segment [Member]                                                                                      |           |            |   |   |   |   |   |   |   |   |   |   |   |
| **Segment Reporting Information [Line Items]**                                                                       |           |            |   |   |   |   |   |   |   |   |   |   |   |
| Net sales                                                                                                            |           |            |   |   |   |   |   |   | 0 |   |   |   |   |
| Net sales                                                                                                            |           |            |   |   |   |   |   |   |   | 0 | 0 |   |   |
| Earnings (losses) from continuing operations before income taxes                                                     |           |            |   |   |   |   |   |   | (243) | (217) | (234) |   |   |
| Income from equity investees                                                                                         |           |            |   |   |   |   |   |   | 0 | 0 | 0 |   |   |
| Total assets                                                                                                         | $ 382          |            |   |   | $ 357 |   |   |   | 382 | 357 |   |   |   |
| Capital expenditures                                                                                                 |           |            |   |   |   |   |   |   | 11 | 6 | 6 |   |   |
| Depreciation and amortization                                                                                        |           |            |   |   |   |   |   |   | 5 | 5 | 6 |   |   |
| Stock-based compensation                                                                                             |           |            |   |   |   |   |   |   | $ 9 | $ 20 | $ 9 |   |   |

| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(11)) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(12)) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details**Name:**us-gaap_Assets**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**instant |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=109250915&loc=d3e13531-108611Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109250915&loc=d3e13537-108611Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592
+ Details**Name:**us-gaap_ConcentrationRiskPercentage1**Namespace Prefix:**us-gaap_**Data Type:**num:percentItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details**Name:**us-gaap_DepreciationDepletionAndAmortization**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 940 -SubTopic 20 -Section 25 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(10)) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(8)) -URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(15)) -URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260
+ Details**Name:**us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(12)) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(10)) -URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(13)(f)) -URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570
+ Details**Name:**us-gaap_IncomeLossFromEquityMethodInvestments**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.
+ References
No definition available.
+ Details**Name:**us-gaap_NumberOfReportableSegments**Namespace Prefix:**us-gaap_**Data Type:**xbrli:integerItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585
+ Details**Name:**us-gaap_PaymentsToAcquirePropertyPlantAndEquipment**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130543-203045Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130539-203045Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045
+ Details**Name:**us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599
+ Details**Name:**us-gaap_Revenues**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                  |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - References
No definition available.
+ Details**Name:**us-gaap_SegmentReportingAbstract**Namespace Prefix:**us-gaap_**Data Type:**xbrli:stringItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details**Name:**us-gaap_SegmentReportingInformationLineItems**Namespace Prefix:**us-gaap_**Data Type:**xbrli:stringItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details**Name:**us-gaap_ShareBasedCompensation**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                              |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                  |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                              |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_StatementBusinessSegmentsAxis=clx_CleaningMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                  |
|------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_SubsegmentsAxis=clx_HomeCareMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                 |
|-----------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_SubsegmentsAxis=clx_LaundryMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                              |
|------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_SubsegmentsAxis=clx_ProfessionalProductsMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_SubsegmentsAxis=clx_BagsWrapsAndContainersMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                  |
|------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_SubsegmentsAxis=clx_CharcoalMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                   |
|-------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_SubsegmentsAxis=clx_CatLitterMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                         |
|-------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_SubsegmentsAxis=clx_DigestiveHealthMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                      |
|----------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_SubsegmentsAxis=clx_FoodProductsMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                             |
|-----------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_SubsegmentsAxis=clx_NaturalPersonalCareMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                         |
|-------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_SubsegmentsAxis=clx_WaterFiltrationMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                            |
|----------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_SubsegmentsAxis=clx_DietarySupplementsMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                     |
|-------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                  |
|----------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                    |
|------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |